"Company CFO John Smiley reported that the pharma giant is planning to clock $1 billion to $5 billion worth of deals for each quarter of 2020."
That's bad news for those who are pinning their hopes on a buyout. It looks like they can't afford us unless they stretch the acquisition across multiple quarters.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.